Risk-free patient recruitment means you don’t pay until your patient randomizes into your clinical trial. See what else SubjectWell can provide at no risk to you.
Location: United States, Texas, Austin
Employees: 51-200
Total raised: $45M
Founded date: 2012
Investors 4
| Date | Name | Website |
| - | Frontier V... | draperfron... |
| - | Frontier O... | frontiervc... |
| 17.07.2021 | ATP Fund | atpfund.co... |
| - | Geekdom Fu... | geekdomfun... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.11.2022 | Series B | $35M | - |
| 19.06.2019 | Series A | $10M | - |
Mentions in press and media 18
| Date | Title | Description |
| 03.06.2025 | Accelerating Patient-Centric Clinical Trials Through Science-Based Planning, Delivery and Support, Upcoming Webinar Hosted by Xtalks | www.subjectwell.com Xtalks will host a free, insightful webinar exploring science-based strategies that streamline clinical trial execution while keeping patient needs and perspectives at the forefront. Speakers from SubjectWell and Verista... |
| 04.02.2025 | SubjectWell Rebrands and Launches OneView Portal to Streamline Patient Recruitment | What You Should Know: – SubjectWell, a company transforming patient recruitment by addressing the greatest challenges in clinical development, today announced the launch of its OneView recruitment portal and company rebrand. – OneView simpl... |
| 03.11.2023 | SubjectWell Acquires PatientCentra | SubjectWell, an Austin, TX-based patient access marketplace that connects patients with chronic health conditions to new care options, announced the acquisition of PatientCentra, an MD Connect, Inc. business. The amount of the deal was not ... |
| 03.11.2023 | SubjectWell Acquires PatientCentra, Expanding Ability to Recruit for Rare Disease/Oncology Indications | What You Should Know: – SubjectWell, a patient access marketplace connecting individuals with chronic health conditions to healthcare options, has acquired PatientCentra, a company specializing in global patient recruitment and personalized... |
| 10.11.2022 | SubjectWell Raises $35M Series B Round | AUSTIN, TX, SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a $35 million Series B funding round. >> Click here for more f... |
| 20.10.2022 | SubjectWell Announces $35M Series B Round | AUSTIN, TX, SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round. >> Click here for more funding data on Subject... |
| 20.10.2022 | SubjectWell Raises $35M in Series B Funding | SubjectWell, an Austin, TX-based provider of an engagement platform matching patients with chronic health conditions, raised $35M in Series B funding. The round was led by Asset Management Ventures, with participation from Bertelsmann Inves... |
| 20.10.2022 | SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases | - |
| 16.03.2022 | Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration | Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabet... |
| 15.05.2020 | SubjectWell Launches Patient Registry of 10k+ Patients for COVID-19 Clinical Trials | What You Should Know: – SubjectWell launches a patient registry list of 10,000 individuals in the US interested in participating in COVID-19 clinical trials and research. – The new COVID-19 patient registry will accelerate the patient recru... |
Show more